Tumor region under externally applied magnetic field

The 'tumor region under externally applied magnetic field' refers to a localized physiological area targeted by physical means rather than a specific biological molecule or receptor. This approach utilizes external magnetic fields to manipulate magnetic nanoparticles (MNPs) or drug carriers within the tumor microenvironment for therapeutic purposes (PubMed: 29035121). The primary applications include magnetic hyperthermia, where alternating magnetic fields generate heat to destroy cancer cells, and magnetic drug targeting, which uses static fields to concentrate therapeutic agents at the tumor site (NIH: PMC5850538). While it serves as a focal point for treatment, it does not possess the characteristics of a canonical therapeutic target like an enzyme or receptor. Instead, it represents a delivery and activation strategy designed to enhance the precision of oncology treatments and reduce systemic side effects (PubMed: 24507691). This modality is often paired with imaging techniques like MRI to monitor nanoparticle accumulation and treatment efficacy in real-time.

Other names

Magnetic drug targeting siteMagnetic hyperthermia zoneMagnetically targeted tumor microenvironmentMagnetic field-responsive tumor site

Physical localization and thermal ablation via magnetic hyperthermia or magnetic force-driven drug delivery.